Modernizing CMV Preventive Approaches

In this episode, Hannah Imlay, MD, MS, discusses cytomegalovirus (CMV) prevention strategies in solid organ transplantation (SOT) recipients including:

• Strategies for preventing CMV in SOT
• International guideline recommendations for CMV prevention strategies by organ type
• Antivirals used for CMV prevention
• Comparison of preemptive therapy vs prophylaxis for CMV prevention in liver transplant recipients
• Comparison of letermovir vs valganciclovir for CMV prophylaxis in kidney transplant recipients
• Use of CMV cell–mediated immunity monitoring for primary prophylaxis
• Monitoring CMV viral loads, including limitations to quantitative nucleic acid testing
• Future prevention approaches

Faculty:

Hannah Imlay, MD, MS
Assistant Professor of Medicine
Department of Internal Medicine, Division of Infectious Diseases
University of Utah  
Salt Lake City, Utah

Content based on a CME program supported by an educational grant from Merck & Co., Inc., Rahway, NJ, USA.

Follow along with a downloadable slideset at: 
https://bit.ly/476v2wI

Link to full program: 
https://bit.ly/47lNK2K